menu search

Outlook Therapeutics® to Present at the SVB Securities Global Biopharma Conference

Outlook Therapeutics® to Present at the SVB Securities Global Biopharma Conference
– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET – ISELIN, N.J., Feb. 07, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, […] The post Outlook Therapeutics® to Present at the SVB Securities Global Biopharma Conference appeared first on ForexTV... Read More
Posted: Feb 7 2023, 13:05
Author Name: forextv
Views: 102027

Search within

Pages Search Results: